Semaglutide vs tirzepatide for weight loss: the honest head-to-head
Semaglutide (Wegovy) and tirzepatide (Zepbound) are two prescription weight-loss shots that work in similar but not identical ways. In big trials, semaglutide 2.4 mg gave about 15% mean weight loss over 68 weeks, and tirzepatide gave about 20-21% over 72 weeks. A head-to-head trial found tirzepatide a bit ahead on average. Both need a doctor, a reduced-calorie diet, and activity, and both share the same class risks. This article compares them honestly so you can talk to your doctor with the facts in hand.
If you are thinking about a prescription weight-loss shot, two names keep coming up: semaglutide (the medicine in Wegovy) and tirzepatide (the medicine in Zepbound). People ask: which one is better? Is tirzepatide just a stronger semaglutide? The honest answer is that they are different molecules, both work well, and in trials tirzepatide tended to produce a bit more weight loss on average. But more weight loss can also mean more side effects, and the choice is never yours alone to make. This is a comparison, not a recommendation. Your doctor chooses based on your body, your other conditions, what is available, what you can afford, and how you tolerate the medicine. Read this so you can ask your doctor better questions.
The baseline: similar class, different molecules, different trial results
Both medicines are given as a once-weekly shot under the skin, along with a reduced-calorie diet and more activity. Semaglutide works on one gut hormone pathway: it is a GLP-1 receptor agonist. Tirzepatide works on two pathways at once: it is a GIP and GLP-1 dual receptor agonist. That is the key science difference, not simply a higher dose of the same drug. In the STEP 1 trial, once-weekly semaglutide 2.4 mg gave a mean body weight change of -14.9% at 68 weeks, vs -2.4% with placebo. In the SURMOUNT-1 trial, once-weekly tirzepatide gave -15.0% at the 5 mg dose, -19.5% at 10 mg, and -20.9% at 15 mg, at 72 weeks, vs -3.1% with placebo. So in their own trials, tirzepatide's higher doses produced more mean weight loss than semaglutide, though the trials were separate and not directly matching. A direct head-to-head trial, SURMOUNT-5, compared them properly and is covered below. Both medicines share the same class risks: a boxed warning about thyroid C-cell tumours seen in rodents, contraindication in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), common stomach side effects, and rare but serious risks like pancreatitis, gallbladder issues, and kidney injury. Neither is for pregnancy.
Tirzepatide is just a stronger version of semaglutide.
VerdictNot exactly. They are different molecules. Semaglutide is a GLP-1 receptor agonist, meaning it works on one gut hormone pathway. Tirzepatide is a GIP and GLP-1 dual receptor agonist, meaning it works on two pathways at once. That dual action is a different design, not simply a higher dose of the same drug. It is true that in trials tirzepatide generally produced more mean weight loss on average - in the head-to-head SURMOUNT-5 trial, tirzepatide gave -20.2% vs semaglutide -13.7% at 72 weeks. But more weight loss is not free: it can also mean more side effects, and the SURMOUNT-5 trial was not even powered to compare safety between the two. The choice is doctor-led, based on your body, your other conditions, availability, cost, and how you tolerate the medicine. Do not chase 'the stronger one' on your own.
If your doctor is considering one of these, here is what actually matters
- Let your doctor choose. The decision depends on your weight, your other conditions (like heart disease, diabetes, thyroid history), what is available near you, cost, and how you handle side effects. This article is a comparison, not a recommendation.
- Do not chase 'the stronger one.' More weight loss in trials can also mean more side effects. The goal is the right medicine for you, not the biggest number on a chart.
- Both need a reduced-calorie diet and more activity. The shot is not doing the work alone. Without food and activity changes, the result is smaller and the regain risk is higher.
- Eat enough protein and keep some resistance work in your week. These medicines can cause muscle loss along with fat loss. Protein and strength work help protect your muscle.
- Know the red flags. Tell your doctor right away if you get severe stomach pain that may spread to the back (possible pancreatitis), yellowing eyes or skin, or signs of dehydration. These are rare but serious.
- Not for pregnancy. Both labels say weight loss offers no benefit to a pregnant patient and may cause fetal harm. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- Expect the dose to climb slowly. Both medicines start low and go up over weeks to help your stomach adjust. Nausea and diarrhea are commonest during this ramp-up and often settle.
- Do not self-source. In India, availability and cost vary a lot and fake or unapproved versions exist. Use a real doctor and a real pharmacy.
The bottom line
Semaglutide (Wegovy) and tirzepatide (Zepbound) are both real, prescription weight-loss medicines, not magic and not interchangeable. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a GIP + GLP-1 dual receptor agonist - a different molecule, not just a stronger dose. In their own trials, semaglutide 2.4 mg gave about 15% mean weight loss at 68 weeks, and tirzepatide gave about 15-21% at 72 weeks depending on dose. In a direct head-to-head trial (SURMOUNT-5, 72 weeks), tirzepatide gave -20.2% vs semaglutide -13.7%, so tirzepatide was a bit ahead on average. Both share the same class risks: common stomach side effects, rare pancreatitis, gallbladder and kidney issues, a thyroid C-cell boxed warning, no use with MTC or MEN 2, and not for pregnancy. In India both have limited availability and significant cost, so do not self-source. Talk to your doctor. The right choice is the one that fits your body, your conditions, what you can get, what you can afford, and what you can tolerate - and it always comes with food, activity, and protein. Burnie logs your food and shows your deficit; the medicine, if your doctor prescribes one, sits on top of that, not instead of it.